Navidea Biopharmaceuticals Announces the Regulatory Approval of Lymphoaim in India

Navidea Biopharmaceuticals Announces the Regulatory Approval of Lymphoaim in India - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

United States ,India ,American ,Shukrit Sudhir Chimote ,Michael Rosol ,Navidea Manocept ,Navidea Biopharmaceuticals Inc ,Securities Exchange ,Sayre Therapeutics Private Ltd ,Sayre Therapeutics ,Chief Medical Officer ,Chief Executive Officer ,Therapeutics Private ,South Asia ,Securities Act ,Securities Exchange Act ,Annual Report ,